A review of depression in the head and neck cancer patient

William M. Lydiatt, Jessica Moran, William J. Burke

Research output: Contribution to journalReview articlepeer-review

125 Scopus citations


Head and neck cancer patients experience among the highest rates of major depressive disorder of all oncology patients with an incidence of 15-50%. Correct diagnosis is critical to expeditious management. Oncologists are not always adept at making the diagnosis as medical and treatment side effects can mimic the signs and symptoms of depression. Treatment can be successful and typically involves medical, social, and psychologic interventions. Causes of depression, obtaining an accurate diagnosis, and treatment options are all discussed in this review.

Original languageEnglish (US)
Pages (from-to)397-403
Number of pages7
JournalClinical Advances in Hematology and Oncology
Issue number6
StatePublished - 2009
Externally publishedYes


  • Depression
  • Head and neck cancer
  • Major depressive disorder
  • Mouth cancer
  • Throat cancer
  • Treatment of depression

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'A review of depression in the head and neck cancer patient'. Together they form a unique fingerprint.

Cite this